The kidney possesses most of the common xenobiotic metabolizing enzymes, and is thus able to make an important contribution to the body's metabolism of drugs and foreign compounds. An overview of the renal localization, catalytic activity, developmental regulation, induction, and sex and species differences for the key enzymes involved in phase I and phase I1 of xenobiotic metabolism is presented. In general, the catalytic activities of the various renal enzymes are lower than those of the liver, although there are exceptions, such as the enzymes involved in the processing of glutathione conjugates to their mercapturic acids. Xenobiotic metabolizing enzymes are not evenly distributed along the nephron; cytochromes P-450 and those enzymes involved in the conjugation of glutathione, glucuronic acid, or sulfate are primarily localized in the proximal tubules. However, some isozymes of cytochrorne(s) P-450 and glutathione S-transferases are selectively localized in cells of the thick ascending limb and distal tubules, whereas prostaglandin H synthase is concentrated in the collecting ducts in the medulla. Thus, the proximal tubule, the principal site of xenobiotic biotransformation, is particularly susceptible to chemical insult, and the localization of prostaglandin synthase in the inner medulla and papilla may be a'contributary factor to the toxicity produced by chemicals in this part of the nephron. Many of the enzymes discussed, in addition to metabolizing foreign compounds, have important endogenous functions in the kidney, such as the regulation of salt and water balance and the synthesis of vitamin D.
INTRODUCTION
The primary route of excretion of xenobiotic compounds from the body is via the kidneys. It is being increasingly recognized that elucidation of renal excretory mechanisms is important in understanding the pharmacologic efficacy and duration of action of drugs and, with certain compounds, the mechanism of nephrotoxicity (7, 8, 17) . Because the kidneys contain drug-metabolizing enzymes, and as all compounds that are excreted in the urine either pass through or concentrate in the kidney, renal metabolism can contribute to the overall metabolism of a xenobiotic. This is best illustrated with the drug morphine, where renal metabolism contributes significantly to overall metabolism in the dog (14), sheep (32), and humans (21). The contribution of the kidney to the metabolism of this opiate has also been demonstrated during the anhepatic phase in patients undergoing orthotopic liver transplantation (2). Several reviews on renal metabolism of drugs and xenobiotics have been published, to which the reader is referred for detailed information (15, 19, 20, 36, 37) . The rodent and rabbit have been the most extensively studied species but information is also available on the human kidney. The aim of this paper is to briefly review the current knowledge of the enzyme systems catalyzing xenobiotic metabolism in the kidney with regard to the distribution of these enzymes within the kidney, the induction of these enzymes by foreign compounds and their developmental regulation, any major sex or species differences, and highlighting the *Address correspondence to: Dr. Edward A. Lock. Zeneca, Central Toxicology Laboratory, Alderley Park, Cheshire S K 10 4TJ. United Kingdom. roles of these enzymes in endogenous metabolism and their relevance to nephrotoxicity.
XENOBIOTIC METABOLlShl
Foreign compounds or drugs that enter the mammalian body can be excreted unchanged into the urine, bile, feces, or expired air. With the exception of exhalation, the ease with which these chemicals are eliminated from the body largely depends on their water solubility. Lipophilic compounds present in the excretory fluids are generally reabsorbed and can thereby concentrate in the body. However, a number of biochemical processes are available that can convert lipophilic compounds to more water-soluble metabolites. This process is called biotransformation and is usually enzymatic in nature; the end result is the formation of a metabolite that is chemically distinct from the parent compound. The metabolites are usually more hydrophilic than the parent compound and therefore are less likely to be reabsorbed in the kidney and thus are excreted in the urine. The enzyme reactions involved in biotransformation are of 2 types: phase I reactions, which involve oxidation, reduction, and hydrolysis; and phase I1 reactions, which are primary conjugation reactions where the parent compound or phase I metabolite is covalently linked to an endogenous molecule (e.g., glucuronic acid or sulfate) producing a conjugate. The addition of this moiety also makes the conjugate available for excretion via a number of transport systems that recognize these molecules and facilitate their excretion from the body. For further information on biotransformation the reader is referred to reviews (3 1,38).
The enzyme systems that catalyze these biotransformations are mainly localized in the liver. Extrahepatic 18 tissues such as the kidney generally have low activity and therefore make less of an overall contribution to wholebody metabolism. However, in certain cases, drug-metabolizing enzymes have an important endogenous role-for example, in the kidney in the synthesis of the active form of vitamin D3. The phase I enzymes are located primarily in the endoplasmic reticulum (microsomal fraction) where they are membrane bound, whereas many of the enzymes involved in phase I1 biotransformation are soluble enzymes located in the cellular cytosol fraction. The catalytic activity of renal drug-metabolizing enzymes can be determined in the whole kidney, dissected regions such as cortex, medulla, or papilla, or in microdissected regions of the nephron, and the activity of these enzymes can be determined in whole homogenates or more typically in microsomal or cytosolic fractions. Alternatively, frozen sections of the kidney can be prepared and the activity of certain enzymes determined by histochemical techniques. The presence of the protein (enzyme) or mRNA coding for the protein can also be determined using Western blot analysis with a specific antibody or Northern blot analysis with a specific probe. The localization of the protein or mRNA can also be determined on fixed sections of renal tissue using immunocytochemistry and in sitii hydridization techniques.
RENAL DRUG METABOLIShl
PIinse Z Xertobiotic Biotrniisfori,zntio,z Enzyines Cytoclzronzes P-450. The cytochromes P-450 (P-450s) are a superfamily of hemoproteins that play a central role in the metabolism of xenobiotics and are involved in the synthesis and catabolism of endogenous compounds. The majority of P-450s are located in the microsomal fraction and they catalyze a wide variety of chemical reactions including oxidative reactions such as aliphatic and aromatic hydroxylation, N-and S-oxidation, epoxidation, N-, S-, and O-dealkylation, desulfuration, and deamination, as well as reductive reactions such as dehalogenation and reduction of azo and nitro groups. Multiple forms of cytochrome P-450 have been identified in many tissues including the kidney, and their nomenclature is based on amino acid sequence homology. Members of families (designated by arabic numerals) and subfamilies (designated by letters, capitals in all species except the mouse) share greater than 39% and 55% sequence homology, respectively. Individual subfamily members are designated by arabic numerals after the subfamily designation (e.g., CYPlAl and CYPlA2). Four gene families (CYP 1-4) contain those P-450s primarily responsible for xenobiotic metabolism. Cytochromes P-450 are, in general, inducible and this has important consequences with regard to the balance of detoxification or activation of a particular chemical. The P-450 subfamilies fall into the following categories on the basis of their inducibility: CYPl A, polycyclic aromatic hydrocarbon inducible; CYP2B, phenobarbital inducible; CYP2E1, ethanol and solvent inducible; CYP3A, steroid inducible; and CYP-4A, hypolipidemic agent inducible.
The renal concentration of total P-450 determined spectrally is low compared to the liver concentration; in the range of 0.1-0.2 nmoVmg protein, compared to the liver at 1.0-1.5 nmoVmg protein. However, early studies by Endou (6), using dissected regions of the rabbit nephron, showed marked regional differences in localization, with the S2 and S3 segments of the proximal tubule generally having higher concentrations. Thus, the use of whole kidney, as opposed to renal cortex or isolated proximal tubular cells, can grossly underestimate the metabolic capability of certain regions in the kidney, such that certain proximal tubular cells could have a similar P-450 content to hepatocytes. Subsequent studies using microdissected regions of the rat nephron with specific substrates has confirmed the preferential localization of certain specific cytochromes P-450 to proximal tubular cells (Fig. 1) . However, this does not mean that other parts of the nephron lack P-450s. For example, arachidonic acid (AA) epoxygenase ( Fig. 1 ) is also present in high concentrations within cells of the ascending limb of the loop of Henle of the rat (18).
The CYPl gene family metabolizes substrates such as benzo [a] pyrene and aflatoxin B, and is important with regard to the generation of mutagenic or carcinogenic metabolites of these compounds. This gene family is present in the kidney and is inducible by chemicals such as 3-methylcholanthrene, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), P-naphthoflavone, and certain polychlonnated and polybrominated biphenyl compounds. Microsoma1 fractions from the kidneys of rats, mice, guinea pigs, hamsters, and human renal cortex have the capability to metabolize arylhydrocarbons. Renal CYPl A1 is only detected after treatment with inducers in the rat and rabbit, where it is located in high concentrations in the proximal tubules. In contrast, CYPlA2 is constitutively expressed in the rabbit kidney and can be induced with TCCD.
The CYP2 gene family is by far the largest family and the most studied (10). In the kidney, members of this family are involved in the hydroxylation of endogenous substrates such as testosterone, estradiol, progesterone, and AA as well as a wide range of xenobiotic compounds including solvents (ethanol, acetone, chloroform), drugs (paracetamol, propranolol), and carcinogens (N-nitrosodimethylamine). Cytochromes P-450 of the CYP2A subfamily show a marked species difference, being expressed in mouse kidney (9, 34) but not in rat kidney (39). In the mouse, the CYP2A cytochrome, which is responsible for the 15-a hydroxylation of testosterone, is under androgenic control; CYP2A is virtually absent in females and castrated male mice. The CYP2B genes show a species-specific constitutive expression and inducibility by phenobarbital. In the rabbit, hamster, and mini-pig CYP2B 1/2 is present at low levels in untreated animals and is inducible with phenobarbital. In contrast, neither CYP2B 1 nor CYP2B2 are expressed constitutively in rat or mouse kidney, nor can they be induced by phenobarbital administration (Fig. 2) .
The CYP2C subfamily is a group of constitutively expressed proteins that in rats is under developmental and sex-specific regulation. Members of the CYP2C subfamily have been shown to catalyze the epoxidation of AA at the 11,12 double bond in rat, rabbit, and human kidney, and the localization of this enzyme activity has been determined along the rat nephron (Fig. 1) . This is of physiologic interest because rat renal epoxygenase can be induced by salt loading, which can protect against hypotension. For additional information on P-450-mediated AA metabolism see Laniado-Schwartzman and Abraham (18) and McGiff (22) .
The CYP2E subfamily contains an important member, CYP2E1, which metabolizes low-molecular-weight chemicals. In the kidney this isoform is induced by ethanol, acetone, pyridine, and pyrazole in a number of species. In the mouse, renal CYP2E1 is under androgenic control, and is present in males to a much greater extent than in females, although treatment of females with testosterone will markedly induce the protein and mRNA in wild type but not in TfriiN androgen receptor-deficient mice (Fig. 3) . CYP2E1 is primarily localized in the prox- imal tubules and its presence in that part of the nephron is believed to account for the nephrotoxicity produced in the male mouse with chemicals such as chloroform, ipomeanol, 1,l-dichloroethene, and paracetamol. The CYP3 family consists of a single subfamily with multiple hepatic members in rats and humans and is the predominant constitutive form of P-450. In the liver these P-450s can be induced by glucocorticoids, such as pregnenolone-l6a-~arbonitrile, and are involved in steroid hydroxylation. This family has been little studied in the kidney, although Murray et a1 (24) showed that CYP3A4 is localized in human renal proximal tubules (Fig. 4) .
The CYP-4 gene family catalyzes the metabolism of fatty acids and AA, and is inducible by hypolipidemic drugs and chemicals that cause peroxisome proliferation. In the rat kidney the main constitutive member of this family is CYP-4A2, which is not inducible by hypolipidemic agents; whereas CYP-4A1 is expressed at a low level, but is highly inducible. The renal expression of CYP-4A2 is higher in male rats than in female rats and appears to be regulated by testosterone, growth hormone, and thyroid hormone. Multiple forms of this family have been isolated and purified from the kidney and shown to catalyze w-and w-1 hydroxylation of AA and lauric acid, and o-hydroxylation of prostaglandin A1 and A2. Studies with dissected nephron segments have shown that w-oxidation of AA to 20-hydroxyeicosatetraenoic acid (HETE) and w-1 oxidation of AA to 19-HETE occurs primarily in the proximal tubule (Fig. 3 , but considerable activity was also found in the distal convoluted tubule and connecting tubule (Fig. 5) .
Epoxide Hydrolase. Epoxide hydrolases are enzymes that catalyze the conversion of epoxides to trans-dihydre diols, thus preventing or reducing the reaction of epoxides with cellular macromolecules such as protein or DNA. The kidney expresses both microsomal and cytosolic epoxide hydrolases, albeit at levels lower than those found in the liver. n o microsomal forms have been identified, 1 catalyzes the conversion of cholesterol 5,Gepoxide to the corresponding diol and has no activity toward xenobiotic epoxides. The other major membrane-bound form is responsible for the hydration of a wide range of xenobiotic arene and alkene oxides, including benzo[a]pyrene-4,5-oxide and styrene oxide. Microsomal and cytosolic epoxide hydrolase activities have been detected in adult human renal cortex and medulla, and in the rat the microsomal enzyme has been immunolocalized to the proximal tubule. Cytosolic renal epoxide hydrolase can be induced by hypolipidemic agents and is under androgenic control in the mouse, in which testosterone will induce enzyme activity with transstilbene oxide as substrate (Fig. 6) .
Microsomul Fluvin-Containing Monooxygenases. This family of microsomal enzymes catalyzes the NADPHdependent oxidative metabolism of a wide variety of N-, S-, and P-containing compounds and has been detected in the kidney. Five distinct flavin-containing monooxygenase (FMO) genes (FMO1-5) have been identified and molecular characterizations of these subfamilies have been performed in a variety of species including humans, although the rabbit has been most extensively studied (13, 30). With the exception of FM03, these enzymes have been detected in rabbit kidney. The distribution of FM02 has been studied in the rat kidney and has been shown to be localized in both the proximal and distal tubules and in the collecting ducts in the medulla. The developmental regulation, inducibility and role these enzymes play in detoxification or activation of xenobiotics in the kidney requires further study.
Prostaglandin H Synthase. This enzyme is bifunctional, containing both cyclooxygenaqe and peroxidase activities. Prostaglandin H synthase (PHS) first converts AA to prostaglandin G2 (cyclooxygenase) and then reduces this metabolite to the corresponding alcohol, prostaglandin H2 (peroxidase). Prostaglandin H synthase-dependent bioactivation of xenobiotics can occur by 3 principle mechanisms. First, the peroxidase can directly oxidize the chemicals. Second, peroxy radicals generated during prostaglandin biosynthesis can be potent oxidizing agents. A third mechanism involves secondary oxidant species formed by the peroxidase (33). The rabbit kidney contains relatively high levels of PHS. Arachidonic acid-mediated metabolism of 1,3-diphenylisobemfuran is highest in the inner medulla, intermediate in the outer medulla, and barely detectable in the cortex (Fig. 7) , whereas with NADPH as substrate P450-mediated metabolism shows the opposite localization (Fig.  7) . Immunocytochemical studies in the rdbbit and guinea pig have shown that the enzyme is primarily localized in the collecting ducts and interstitial cells of the medulla and papilla. Several xenobiotics are substrates for renal PHS, including acetaminophen, nonsteroidal anti-inflammatory drugs, antipyretics, and mild analgesics. some of which can biotics containing an ester, thioester, or amide group. In rodent kidney, carboxylesterases will hydrolyze a number of substrates including 4-nitrophenyl acetate, palmitoyl coenzyme A, and the pesticide malathion. A carboxylesterase designated hydrolase B was recently cloned from a rat kidney cDNA library, and its mRNA was shown to be present at higher levels in the kidney than in the liver. Immunocytochemical studies with an antibody to hydrolase B have shown that the enzyme is localized in the proximal tubules (40). 'Histochemical studies in the rat kidney using P-naphthyl acetate as substrate have also shown localization to the proximal tubules (Fig. 8) . Two other carboxylesterases, designated hydrolase A and hydrolase C, are also present in the kidney but at much lower levels than hydrolase B.
Phase 11 Xertobiotic Biotmitsforinatioit Enzymes
Glzrtatltioite S-Tmnsfernses. Glutathione (GSH) conjugation is the formation of a thioether link between the tripeptide GSH and a compound with a electrophilic center. This process is catalyzed by the glutathione S-transferases of cytosolic GSTs, plus the trimeric microsomal form, but at a low level relative to the liver. In the rat kidney, biochemical studies have shown that the major GST subunits are 1, 2, 4, 7, and 8. Immunocytochemical studies have localized the alpha subunits (1, 2, and 8) to the proximal tubule (Fig. 9A) . The mu subunit 3 was detected in the distal tubule (Fig. 9B) , collecting ducts (Fig. 9C) , and the urothelium. Subunits 4 and 6 were detected along the nephron from the thin ascending limb to the collecting ducts, and the pi class (subunit 7) was found in the thin loop of the rat nephron, GSTs of the alpha class were selectively expressed in the proximal tubules and the mu and pi classes were expressed in the thin loop of Henle and distal tubules (29). A similar pattern has been detected in human kidney, with the mu class being absent or present at a low level (1). During development of the human kidney, the relative contribution of the alpha and pi classes alters markedly. The alpha class is only weakly expressed up until birth and does not achieve adult levels of expression until about 40 wk of postnatal age, whereas the pi class begins to fall after 40 wk of postnatal age. Expression of the mu class is little changed during development (1 1). Early studies reported that rat renal GST activity with various substrates was induced by 3,4-benzo[n]pyrene, phenobarbital and 3-methylcholanthrene. However, mo$ recent studies using high-performance liquid chromatography to separate the various subunits or immunoblotting with antisera to the various GST classes has shown that the subunit profile does not change with phenobarbital or 3-methylcholanthrene. In contrast, administration of the antioxidant ethoxyquin results in a 4-fold increase in subunit 7 (pi class) and a doubling of subunit 4 (mu class).
Mercrrpfiiric Acid Syiitliesis. The kidney plays an important role in the degradation of GSH conjugates to their corresponding mercapturic acids. First, the isopeptide bond between the a-carbonyl of glutamate and the amino group of cysteine is cleaved by y-glutamyltransferase, and then aminopeptidase M or cysteinylglycinase (CG) cleaves the resulting S-cysteinylglycine conjugate to yield the cysteine conjugate. In the rat, these enzymes are rich in the brush border membranes of the proximal tubule, forming the cysteine conjugate in the tubular lumen. The S-cysteine conjugate may then be excreted, but frequently it is reabsorbed and mercapturic acid synthesis is completed by N-acetylation to give an N-acetyl-S-cysteine conjugate. This latter reaction is catalyzed intracellularly by a microsomal N-acetyltransferase (NAT). Both the liver and kidney contain this enzyme, the specific activity in the kidney is twice that in the liver. The kidney also possesses enzymes that can deacetylate mercapturic acids (DA), and activity has been reported in rat, rabbit, and guinea pig kidney with several S-alkyl, S-aralkyl, and Saryl mercapturic acids. Deacetylation of haloalkane and haloalkene S-cysteine conjugates can make them substrates for the enzyme cysteine conjugate p-lyase, which is an activation pathway. Thus, the balance between Nacetylation and N-deacetylation of these haloalkane and haloalkene S-conjugates plays a key role in the nephrotoxicity produced by these chemicals.
Processing of GSH-Conj ugates
The formation, processing, and transport of GSH conjugates occurs in a number of organs including the liver, biliary tract, gastrointestinal tract, and kidney, and involves considerable inter-and intraorgan cooperation (3, 12; L. H. Lash, p. 33, this issue) .
Cysreiiie Coirjiigate p-Lyase. Cysteine conjugate p-lyase is a pyridoxal phosphate-dependent enzyme that is able to metabolize S-cysteine conjugates via both transamination and p-elimination. Isolation and protein sequence studies have shown that cysteine conjugate p-lyase is identical to glutamine transaminase K and catalyzes the transamination of hydrophobic amino acids such as phenylalanine (35) . In addition, recent cloning studies have shown that p-lyase also possesses kynurenine aminotransferase activity (23). Both rat and human renal plyase have been cloned, sequenced, and expressed in COS-1 cells, and the expressed enzymes showed catalytic activity with both S-cysteine conjugates and phenylalanine (26, 27) . In the rat kidney the enzyme is present mainly in the cytosol, but also to a lesser extent in the mitochondria. P-Lyase has been shown to play a critical role in the nephrotoxicity of certain S-cysteine conjugates such as 1,2-dichlorovinyl-~-cysteine (DCVC) or 1,2,3,4,4-pentachloro-1,3-butadienyl-~-cysteine (PCBC). Immunocytochemical studies have localized the enzyme to the proximal tubule of the rat kidney, the primary site of morphologic damage produced by nephrotoxic cysteine conjugates. Recently, P-lyase activity using DCVC as substrate has been determined along the rat nephron and detected in the S1, S2, and S3 regions of the proximal tubule, but not elsewhere (16). The renal enzyme is not readily inducible; treatment of rats with nonnephrotoxic doses of PCBC produces only a 1.5-to 3-fold increase in enzyme activity, protein content, and the cognate RNA.
Uridiiie Diphospkate Gliiciiroiiosyltrcriisfercrses. Conjugation with glucuronic acid is a major pathway in the biotransformation and elimination of a wide variety of lipophilic compounds of both endogenous and exogenous origin. The glucuronides formed are, in general, less biologically active and more polar than their aglycone substrates and hence are more readily excreted in the urine. Glucuronidation reactions are catalyzed by 2 families of closely related uridine diphosphate glucuronosyltransferases (UDPGTs) (4). Cloning studies using cDNA libraries from human liver have identified a number of novel UDPGT isoforms and a nomenclature similar to that for the P-450s has been suggested. The UGTl subfamily contains 4 enzymes; 2 of these glucuronidate bilirubin, and the other 2 glucuronidate small planar and bulky phenols. The UGT2 subfamily isoforms have been shown to glucuronidate steroids, including bile acids and catechol estrogens.
Renal glucuronidation of a wide range of substrates has been demonstrated with both phenols and steroids, suggesting that both UDPGT families are present. The UDPGTs are not uniformly distributed along the nephron. Initial studies with a number of substrates showed that catalytic activity was higher in the cortex than in the medulla. Immunocytochemical studies in both rat and human kidney have confirmed this, demonstrating intense LOCK AND REED TOX~COLOGIC PATHOLOGY reactivity in the proximal tubules with less reactivity in the distal tubules. In human kidney, during early fetal development UDPGT immunoreactivity was found to be widespread throughout the collecting duct and tubular systems, but as the nephrons developed the enzyme became predominantly localized in the proximal tubules. Sex and species differences have been identified in renal glucuronidation. For example, the rat kidney is unable to conjugate morphine, and the human kidney is deficient in bilirubin conjugation. Renal UDPGTs can be induced by classical inducing agents such as TCDD, P-naphthoflavone, clofibrate, and trans-stilbene oxide, but in general the increase is not very marked. Sirlfotraiisferases. Sulfation is an important pathway of metabolism for a range of endogenous compounds including bile acids, steroid hormones, and neurotransmitters. Sulfation reactions involve the transfer of the sulfate group from 5'-phosphoadenosine 3'-phosphosulfate to an appropriate functional group such as amino or hydroxyl, by a family of sulfotransferase enzymes present in the cytosol of most tissues including the kidney (5). Sulfation of xenobiotics generally, but not exclusively, leads to reduced biological activity. Sulfotransferase activity with naphthol as substrate gave a similar activity in rabbit renal cortex and medulla, whereas in rat and human tissue immunocytochemical localization using an antibody to rat liver paracetamol sulfotransferase showed the highest content in the proximal tubules, with some localization in the collecting ducts in the medulla. Several groups of researchers have examined the localization of hydroxysteroid sulfotransferases in the rat and human kidney and found little or no expression of this subfamily in renal tissue. Others have shown catalytic activity in the rat renal cortex and medulla and immunocytochemical localization in the proximal tubules and collecting ducts. Generally, this family of enzymes has been little studied in the kidney and as a result information on species and sex differences and the inducibility of various isoforms is very limited.
